Katherine Irene Fogertey, the Chief Financial Officer of $SHAK, sold 1,243 shares of the company on 07-07-2025 for an estimated $176,154. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.6% of their shares of this class of stock. Following this trade, they now own 33,253 shares of this class of $SHAK stock.
$SHAK Insider Trading Activity
$SHAK insiders have traded $SHAK stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $SHAK stock by insiders over the last 6 months:
- DANIEL HARRIS MEYER has made 0 purchases and 8 sales selling 70,000 shares for an estimated $9,594,029.
- KATHERINE IRENE FOGERTEY (Chief Financial Officer) has made 0 purchases and 11 sales selling 7,391 shares for an estimated $974,856.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SHAK Hedge Fund Activity
We have seen 200 institutional investors add shares of $SHAK stock to their portfolio, and 183 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 1,383,999 shares (+111.9%) to their portfolio in Q1 2025, for an estimated $122,027,191
- CITADEL ADVISORS LLC added 1,022,917 shares (+3717.9%) to their portfolio in Q1 2025, for an estimated $90,190,591
- BALYASNY ASSET MANAGEMENT L.P. removed 648,568 shares (-72.5%) from their portfolio in Q1 2025, for an estimated $57,184,240
- AMERIPRISE FINANCIAL INC added 467,748 shares (+144.3%) to their portfolio in Q1 2025, for an estimated $41,241,341
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 444,931 shares (-61.1%) from their portfolio in Q1 2025, for an estimated $39,229,566
- SQUAREPOINT OPS LLC added 378,489 shares (+75.7%) to their portfolio in Q1 2025, for an estimated $33,371,375
- HOLOCENE ADVISORS, LP removed 375,551 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $33,112,331
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SHAK Analyst Ratings
Wall Street analysts have issued reports on $SHAK in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 07/09/2025
- Oppenheimer issued a "Outperform" rating on 06/26/2025
- Barclays issued a "Overweight" rating on 06/26/2025
- JP Morgan issued a "Underweight" rating on 06/25/2025
- Goldman Sachs issued a "Buy" rating on 06/04/2025
- Raymond James issued a "Strong Buy" rating on 05/02/2025
- Loop Capital issued a "Buy" rating on 04/01/2025
To track analyst ratings and price targets for $SHAK, check out Quiver Quantitative's $SHAK forecast page.
$SHAK Price Targets
Multiple analysts have issued price targets for $SHAK recently. We have seen 14 analysts offer price targets for $SHAK in the last 6 months, with a median target of $126.0.
Here are some recent targets:
- Jake Bartlett from Truist Securities set a target price of $160.0 on 07/09/2025
- Alton Stump from Loop Capital set a target price of $127.0 on 07/08/2025
- Jeffrey Bernstein from Barclays set a target price of $166.0 on 06/26/2025
- Andrew Charles from TD Securities set a target price of $105.0 on 06/26/2025
- Brian Bittner from Oppenheimer set a target price of $160.0 on 06/26/2025
- Sara Senatore from B of A Securities set a target price of $134.0 on 06/25/2025
- John Ivankoe from JP Morgan set a target price of $110.0 on 06/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
